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Abstract Homozygous rolling Nagoya natural mutant
mice display a severe ataxic gait and frequently roll over
to their side or back. The causative mutation resides in the
Cacna1a gene, encoding the pore-forming α1 subunit of
Cav2.1 type voltage-gated Ca
2+ channels. These channels
are crucially involved in neuronal Ca
2+ signaling and in
neurotransmitter release at many central synapses and, in
the periphery, at the neuromuscular junction. We here
review the behavioral, histological, biochemical, and
neurophysiological studies on this mouse mutant and
discuss its usefulness as a model of human neurological
diseases associated with Cav2.1 dysfunction.
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Introduction
The ataxic mouse rolling Nagoya (RN) is a natural mutant
of which the neurological phenotype and cerebellar
characteristics have been studied quite extensively in the
first years following its initial report back in 1973 by Oda
[1]. Research on this mouse mutant revived in 2000 when
the causative mutation was identified in the Cacna1a gene,
encoding the pore-forming α1 subunit of Cav2.1 (P/Q-type)
voltage-gated Ca
2+ channels [2]. This type of channel is
involved in neuronal Ca
2+ signaling and also in neurotrans-
mitter release at many central synapses as well as the
neuromuscular junction (NMJ) in the periphery [3, 4]. The
discovery of the RN mutation in Cacna1a was of particular
interest because mutations in the orthologous human gene
had in the meantime been identified in patients suffering
from inherited forms of migraine and ataxia [5]. Besides, the
same Cav2.1 channels were shown to be the autoimmune
targets at the NMJ in the paralytic disorder Lambert–Eaton
myasthenic syndrome (LEMS) [6]. These developments,
therefore, designated the RN mouse (together with other
Cav2.1 mouse mutants) as a potential model for Cav2.1-
channelopathies. In this review, we will provide an overview
on the neurochemical, -physiological, and -morphological
findings in the RN mouse and will discuss its usefulness in
studying ataxia, migraine, and neuromuscular synapse
dysfunction.
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The RN mutant mouse was first described 35 years ago by
Oda [1]. It was identified as a natural mutant among
descendants of a cross between the SIII and C57Bl/6JNA
strains but maintained on a C3Hf/Nga background [1].
Later studies showed that the RN mutation was allelic to
the tottering mutation, which had been mapped on
chromosome 8 [7]. A prominent phenotype in homozygous
RN mice is a broad-based, severe ataxic gait with motor
deficits that are characterized by frequent lurching of the
mice and abnormal cyclic movements of the hind limbs
when walking (Fig. 1). These symptoms of motor dis-
turbances of the hind limbs and balancing difficulties
become noticeable between postnatal days 10 and 14. RN
mice do not show trunk tremor during movement or at rest.
In addition, they have a 25–30% reduction in body weight
[8, 9]. The motor symptoms in RN males make coitus
difficult, causing a reduced breeding capacity. Females are
fertile but produce less surviving offspring due to poor
nursing abilities [7]. Still, once successfully gone through
the weaning period, RN mice have a normal life span [7].
Heterozygous RN mice display no overt neurological
symptoms.
A more detailed characterization of ataxia in RN revealed
abnormalities in several motor tasks [10]. For instance,
compared to wild-type littermates, RN mice underper-
formed by frequent falling from a 2-mm-thin horizontal
wire or by falling or showing persistent exhibition of head-
upward descent from a thick vertical rope, whereas wild-
type mice from postnatal day 16 predominantly used a
head-downward descent. In addition, footprint analysis
revealed that RN mice used “double stepping of the same
hind limb” in an attempt to compensate for their locomotor
disability and being able to transverse forward as well as
possible. In addition to the motor coordination defects and
body weight reduction, RN mice exhibit muscle weakness
[9]. This was shown in grip strength measurements that
revealed a 62% reduction in pulling force compared to wild
type. In addition, fatigability of limb muscles of RN mice
was demonstrated in the inverted grid hanging test: hanging
times of RN mice ranged from only 7 to 16 s, whereas
almost all wild-type mice completed the maximum record-
ing period of 300 s.
The severity of the phenotype in RN mice is intermedi-
ate to that of other natural Cav2.1 mouse mutants (Table 1).
The ataxia is more severe than in tottering but less severe
than in leaner mice. Notably, RN mice do not show the
absence or motor seizures present in the latter mutants [11],
nor do they exhibit paroxysmal dyskinesis as seen in
tottering mice [12]. Interestingly, compound heterozygous
mice with RN and tottering alleles show abnormal
locomotor activities and a wobbly gait of the RN mice,
but not the typical epileptiform seizures seen in the
tottering mice.
Locus of the Rolling Nagoya Mutation
The RN mouse mutation was only relatively recently
mapped to the Cacna1a gene, located on mouse chromo-
some 8, encoding the pore-forming α1-subunit of neuronal
Cav2.1 (P/Q-type) Ca
2+ channels [2]. The mutation is a C-
to-G change at nucleotide position 3784 of the gene that
results in a charge-neutralizing amino acid change from a
highly conserved arginine to glycine at position 1262 in the
Cav2.1-α1 protein (Fig. 2). The R1262G mutation disturbs
the characteristic pattern of positively charged amino acids
of one of the channel’s voltage sensors, localized in the
fourth transmembrane segment of the third repeating
domain, which reduces the voltage sensitivity of the
channel (see below).
Cav2.1 channels belong to the group of high voltage-
activated Ca
2+ channels that also includes Cav1 (L-type),
Cav2.2 (N-type), and Cav2.3 (R-type) channels. Localized
in the membranes of both cell bodies and presynaptic
terminals [3, 4], Cav2.1 channels are involved in neuronal
Ca
2+ signaling pathways, including those involved in gene
expression [13], and are key mediators of neurotransmitter
release in both the central and the peripheral nervous
Fig. 1. Homozygous rolling
Nagoya mice while rolling on
their back (left panel) or side
(right panel). Wild-type litter-
mate at top of left panel
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studies have shown that Cav2.1 protein and mRNA are
abundantly and broadly distributed over almost all brain
areas, with a particularly high expression in the cerebellum
[3, 14-16]. In the periphery, Cav2.1 channels are present at
presynaptic motor nerve terminals at the NMJ [4, 17]. In
vivo, the Cacna1a-encoded Cav2.1-α1 subunit is associated
with auxiliary subunits of the α2δ, β, and γ families, which
modulate the properties of the channel. In recent years, a
large number of mutations in the Cav2.1 channel has been
identified and shown to underlie several human neurolog-
ical disorders, including inherited forms of migraine,
episodic ataxia, and epilepsy (Table 2)[ 18].
Morphological Studies of Rolling Nagoya Cerebellum
and Other Brain Areas
Many studies investigated RN brain anatomy and morphol-
ogy as well as the expression and distribution of neuro-
transmitter receptors in the RN brain. Since the early
studies on cerebellar anatomy, there has been a controversy
on the presence or absence of cerebellar atrophy and
apoptosis. While some of the older studies showed a small
cerebellar volume, reduced weight and a reduction in the
total number of granule, basket, and superficial stellate
cells, others found a normal anatomy (for summary
overview, see “Introduction” of [19]). More recent studies
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Fig. 2. Transmembrane topolo-
gy of the Cav2.1-α1 protein,
with the location of the rolling
Nagoya arginine-to-glycine mu-
tation at position 1262
(R1262G) in the voltage-sensing
S4 segment of the third repeat-
ing domain. Also indicated are
the localizations of the muta-
tions of other Cacna1a mouse
mutants
Table 1 Genetic, behavioral, neuropathological, and electrophysiological characteristics of the rolling Nagoya mouse in comparison to other
natural and induced Cacna1a mouse mutants
Mutant Cacna1a mutation Neurological phenotype Cerebellar
atrophy
Main electrophysiological
defects Cav2.1
References
Symptoms Dominant
or recessive
rolling Nagoya Missense R1262G Ataxia r ? Positive shift activation voltage [2]
Reduced current density
tottering Missense P601L Ataxia, epilepsy,
dyskinesia, dystonia
r − Reduced current density (?) [2, 6, 59-62]
leaner Splice site mutation:
truncated and aberrant
cytoplasmatic
C-terminus
Severe ataxia, epilepsy,
premature death
r + Reduced current density [61-63]
Positive shift activation voltage (?)
rocker Missense T1310K Ataxia, epilepsy,
intention tremor
r − Reduced current density [64, 65]
wobbly Missense R1255L Ataxia d + Not studied yet [66]
Cacna1a
tg-4J Missense V581A Ataxia, epilepsy r − Positive shift activation voltage [67]
Cacna1a
Tg-5J Missense R1252Q Ataxia, premature death
(of homozygote)
d − Negative shift activation voltage [67]
R192Q knockin Missense R192Q None na − Negative shift activation voltage [54]
knockout null Ataxia, epilepsy r + Absent current [68, 69]
d dominant, r recessive, na not applicable, + present, − absent, ? controversial
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4-week-old RN mice, no abnormalities in cerebellar
anatomy nor apoptosis was observed [2], and deep
cerebellar nuclei of 4- to 8-month-old RN mice had a
normal cell density [20]. In contrast, others have reported
(cerebellar granule cell) apoptosis in 4-month-old [21] and,
especially in the anterior lobe, in 3-week-old RN mice [22].
The reasons for these discrepancies remain unclear.
In deep cerebellar nuclei, increased numbers of Cav2.1-
α1 positive neurons have been shown with immunohisto-
chemistry, possibly as a compensatory response to reduced
Cav2.1 activity due to the RN mutation (see below) [20].
RN mice show ectopic tyrosine hydroxylase (TH)
expression in the cerebellum [2, 20, 23], as also found in
the other Cav2.1 mouse mutants tottering [24]a n dleaner
[25]. TH is normally expressed only during development
and ectopic TH expression in Cav2.1 mutants may thus be
a sign of delayed neuronal maturation. Interestingly, no
enzymatically active form of TH, i.e., phosphorylated at
serine residue 40, was identified in the RN cerebellum
[26], suggesting that there is no aberrant catecholamine
synthesis. Because the Ca
2+ concentration in Purkinje
cells is an important determinant of TH expression [27,
28], the ectopic TH expression in RN cerebella is likely
the direct result of Ca
2+ dysregulation following from
Cav2.1 dysfunction.
Increased levels of corticotropin-releasing factor (CRF)
were found in some climbing fibers as well as in mossy
fibers and inferior olive neurons of the RN cerebellum [20,
29, 30]. Interestingly, increased CRF immunoreactivity in
climbing fibers correlated with TH-positive Purkinje cells
[20]. CRF is a neuropeptide that is widely expressed
throughout the central nervous system (CNS) where it acts
as a neuromodulator. In Purkinje cells, CRF increases
glutamate and reduces γ-aminobutyric acid (GABA)
sensitivity [31]. Furthermore, it can potentiate Cav1 (L-
type) currents [32]. It is perceivable how a similar
mechanism in the RN cerebellum could result in Ca
2+
dysregulation and cause ectopic TH expression. Of note,
Cav1.2 channels are selectively upregulated in the cerebel-
lum, but not forebrain, of tottering mice [33], which also
show prominent ectopic TH expression.
Expression of ryanodine receptors type 1 and 3 is altered
in the RN cerebellum [34], indicating a possible disturbance
of intracellular Ca
2+ mobilization from the endoplasmatic
reticulum. Autoradiography studies have shown reduced
levels of GABAA and adenosine A1 receptors in the
cerebellum and of A1 receptors in the cerebral cortex and
caudate-putamen. Furthermore, benzodiazepine binding
sites were found reduced in the cerebral cortex and
increased in the CA1 subfield of the hippocampus [35].
Although the motor disturbances in RN mice are
generally typified as cerebellar ataxia, based on behavioral,
histological, and physiological analyses (see below), some
features also suggest extrapyramidal disturbances. In-
creased local cerebral glucose utilization (indicating en-
hanced neuronal activity) in the basal ganglia (including the
globus pallidus, entopeduncular nucleus, substantia nigra
reticulate, and subthalamic nucleus) as well as electrophys-
iological abnormalities recorded in the globus pallidus have
led to the hypothesis that motor disturbances of RN mice
may perhaps in the end be not so much due to cerebellar
dysfunction but rather due to striatial dysfunction [19, 36].
In addition, radiochemical studies have shown increased
preproenkephalin and preprotachykinin mRNA in the
striatum [37]. More research is clearly needed to shed light
Table 2 Human Cav2.1 channelopathies
Disorder Main symptoms Etiology References
Familial hemiplegic migraine
type-1
Migraine attacks with aura Genetic: missense mutations
in CACNA1A
[5, 18]
Hemiparesis during migraine aura
Sometimes (progressive) ataxia
Episodic ataxia type-2 Ataxic episodes with mildly progressive baseline ataxia Genetic: truncation, deletion and
missense mutations in CACNA1A
[5, 18, 49]
Interictal nystagmus
Sometimes muscle weakness
Spinocerebellar ataxia type-6 Late onset, slowly progressive ataxia Genetic: CAG trinucleotide
expansion in CACNA1A
[48, 70]
Dysarthria
Nystagmus
Rare forms of epilepsy Generalized tonic-clonic epileptic seizures Genetic: missense and truncation
mutations in CACNA1A
[71, 72]
Absence epilepsy
Episodic ataxia
Lambert–Eaton myasthenic
syndrome
(Proximal) muscle weakness Autoimmune: anti-Cav2.1
auto-antibodies
[73]
Often small-cell lung cancer
Sometimes autonomic dysfunction (dry mouth, impotence)
Sometimes ataxia
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causes motor dysfunction in RN mice.
Taken together, there is much histological and biochem-
ical evidence of altered expression levels of a multitude of
intracellular and membrane proteins in many structures of
the RN brain. These changes may, in principle, all
contribute to motor dysfunction but must be secondary
(developmental or compensatory) phenomena resulting
from the primary defect in RN, namely a disturbed Ca
2+
signaling due to the dysfunction of Cav2.1 channels
resulting from the RN missense mutation.
Functional Consequences of the Rolling Nagoya
Mutation in Cav2.1 Channels
The consequences of the RN mutation on the biophysical
properties of Cav2.1 channels have been investigated both
in primary Purkinje cell cultures obtained from RN mice
and in a heterologous expression system [2]. When
expressing RN-mutated Cav2.1-α1 in baby hamster kidney
cells that also stably express the auxiliary subunits α2δ and
β1a, whole cell peak current density (with Ba
2+ as charge
carrier) was reduced by nearly 75%, compared with the
wild-type control. Furthermore, the mutation affected the
voltage dependence of activation of Cav2.1 channels,
shifting the midpoint of activation by ~10 mV in the
positive direction and increasing the slope factor by ~2 mV,
demonstrating a shallower voltage dependence. In contrast,
the voltage of inactivation of RN Cav2.1 channels was
unaffected in these experiments. Cav2.1 type Ca
2+ currents
measured in native cerebellar Purkinje cell bodies were
similarly affected by the RN mutation, showing reduced
density (~25%), a positive shift (~8 mV) of the midpoint of
the voltage of activation, and a ~1 mV increase of the slope
factor. In contrast to heterologously expressed channels, the
inactivation voltage midpoint was shifted by ~9 mV in the
positive direction in native RN Purkinje cells. The finding
of a reduced voltage sensitivity nicely demonstrates that the
R1262G mutation indeed affects the function of the voltage
sensor of Cav2.1 channels, resulting in diminished Cav2.1
activity in Purkinje and other cells expressing this channel,
which likely is the initial factor in the cascade that
ultimately results in the ataxic RN phenotype.
Neurophysiological Effects of the Rolling Nagoya
Mutation
Aberrant Firing Pattern in Purkinje Neurons
Current-clamp analyses at Purkinje cell somata in RN brain
slices revealed a disturbed firing pattern of action potentials
upon stimulation with large depolarizing currents [2]. The
repetitive firing of Na
+ action potentials was aborted due to
interspike depolarization, reminiscent of the effect of
blocking Ca
2+-activated K
+ channels by Cd
2+ in wild-type
neurons. These channels are important for post-spike
repolarization and are presumably activated by the Ca
2+
influx through Cav2.1 channels on the soma and dendritic
tree of the Purkinje cell. Apparently, reduced Cav2.1
function in RN Purkinje cell dendritic tree and/or soma
leads to impaired repolarization, causing impairment of
high-frequency spiking. Reduced current through RN-
mutated Cav2.1 channels was further indicated by the
observation that Ca
2+ spikes were hard to evoke in RN
cells. Together, these experimental findings suggest that the
RN mutation impairs the neuronal firing behavior of
Purkinje cells (in response to synaptic integration) and thus
affects cerebellar neuronal network function, contributing
to the ataxia. Similar observations have been made in other
Cav2.1-mutant mice [38]. These findings do not exclude
involvement of brain areas other than the cerebellum in
causing the movement abnormalities of RN mice. For
instance, spontaneous firing rate of globus pallidus neurons
in the basal ganglia is increased, likely resulting from a
diminished inhibitory input [19].
Synaptic Dysfunction
Cerebellum
Cerebellar synaptic dysfunction in RN mice is highly likely
in view of the demonstrated causative mutation in Cav2.1-α1
and the abundance of this channel at cerebellar nerve
terminals [3]. Cerebellar cortical Purkinje cell dendrites
receive extensive (excitatory) synaptic input from nerve
terminals of climbing and parallel fibers, and there are many
other synaptic connections within the cerebellum that
contribute to network function [39]. There has been only
very limited study of the details of cerebellar synaptic
transmission in the RN mouse. Neurochemistry studies in
cerebellar homogenates showed increased concentration of
neurotransmitters glutamate, serotonin, noradrenaline, and
dopamine and decreased glycine [8, 40]. Morphological
studies showed abnormally shaped Purkinje cell dendritic
spines and single parallel fiber varicosities making multiple
synaptic contacts, not observed in the wild-type [21]. While
these biochemical and histological studies roughly indicated
neurotransmission deficits in the RN cerebellum, they did
not provide detailed insight in the synaptic dysfunction. To
our knowledge, there is only one study in which cerebellar
synaptic function in RN mice was characterized with direct
and detailed electrophysiological measurements. Matsushita
and colleagues [41] measured with voltage-clamp methods in
brain slices the glutamatergic synaptic currents originating
226 Cerebellum (2009) 8:222–230from neurotransmission in parallel fiber as well as climbing
fiber synapses on Purkinje cells. They found reduced
excitatory postsynaptic currents at parallel fiber synapses,
with increased paired-pulse facilitation. With Ca
2+ channel
type-selective toxins, it was shown that presynaptic Ca
2+
influx at wild-type parallel fiber synapses is jointly mediated
by Cav2.1, -2.2, and presumably -2.3 type channels, where
Cav2.1 is the predominant subtype. In RN, the Cav2.1
contribution is somewhat reduced, while those of Cav2.2 and
-2.3 are somewhat increased. Interestingly, the situation in
climbing fiber synapses is completely different. Excitatory
postsynaptic currents in these synapses are enhanced and
display a slower decay phase, compared to wild type. There
is normal triggering of Purkinje cell spikes by climbing fiber
synaptic transmission. Specific Cav2.1 contribution to
neurotransmitter release was found clearly reduced, while
that of Cav2.2 was increased. Pharmacological analyses
indicated that the increased and broadened excitatory
postsynaptic currents are rather due to increased postsynaptic
sensitivity to glutamate than to increased presynaptic release.
Neuromuscular Junction
Besides being a predominant presynaptic Ca
2+ channel in the
CNS, Cav2.1 channels are also present in the peripheral
nervous system at intramuscular motor nerve terminals
where they mediate the release of acetylcholine (ACh) at
the NMJ [4, 17, 42]. Therefore, NMJ dysfunction is to be
expected in Cacna1a-mutant mice. We have tested this
hypothesis with detailed electrophysiological methods in
several mutants [43-45], including RN [9]. We observed a
large reduction (50–75%, depending on the muscle type) of
nerve stimulation-evoked ACh release at RN NMJs (Fig. 3).
Interestingly, this was accompanied by a ~3-fold increase of
spontaneous ACh release, measured as miniature endplate
potential frequency. RN is the only Cacna1a mouse mutant
so far in which opposing effects on spontaneous and evoked
ACh release were found by us. Most likely, they result from
a complex effect of the mutation on different functional
channel parameters, allowing for increased Ca
2+ influx at
resting potential while limiting Ca
2+ influx upon depolariza-
tion by a nerve impulse. Compensatory non-Cav2.1 channels
appear to be absent, as the selective Cav2.1 channel blocker
ω-agatoxin-IVA reduced evoked ACh release by ~95% in
both wild-type and RN NMJs. Reduced ACh release at
NMJs most likely underlies the muscle weakness and fatigue
we observed in grip strength and inverted grid hanging tests
of RN mice; this was further substantiated by our finding of
a reduced and decrementing compound muscle action
potential with in vivo electromyography and a reduced
safety factor of neuromuscular synaptic transmission in ex
vivo muscle contraction experiments. Therefore, our NMJ
studies indicate that the gait abnormality of RN mice is likely
due to a combination of ataxia and muscle weakness and that
the RN mouse models, besides ataxia, aspects of the NMJ
dysfunction in LEMS (see below), where presynaptic Cav2.1
channels are targeted by auto-antibodies [6].
Does the Rolling Nagoya Mouse Form a Good Model for
(Aspects of) Human Neurological Disease?
Ataxia
The ataxic phenotype of RN mice has been described in
much detail [10] and is not “contaminated” by epileptic
seizures, as seen in other Cacna1a-mutant strains such as
tottering, leaner, rocker,a n dnull-mutants (Table 1)[ 46, 47].
Therefore, the RN mouse seems a valuable ataxia model,
suitable for testing the anti-ataxic properties of (experimen-
tal) drugs, especially in the context of human CACNA1A
mutation-related cerebellar ataxia [5, 48, 49]. Such studies
are needed because current drug treatment of ataxia is not
optimal [50]. Only a few compounds (such as acetazolamide
in episodic ataxia type 2) have been reported to improve
ataxia, but none of them has been studied in a controlled or
comparative way [49]. Surprisingly, few anti-ataxic drug
studies have been performed using the RN mouse mutant as
ataxia model. Two studies have shown anti-ataxic effects of
thyrotropin-releasing hormone and synthetic analogs (with
only minor hormonal activity) in RN mice, possibly due to
yet undefined neuroprotective or metabolic effects on RN
brain areas [8, 51]. It would be of interest to test the effect of
drugs acting on Ca
2+-activated K
+ channels, in view of the
likely involvement of these channels in aberrant action
potential firing of cerebellar Purkinje cells of RN [2]a n d
other ataxic Cacna1a-mutant mice [38].
wild-type RN
5 mV
5 ms
Fig. 3. Reduced amplitude of the endplate potential due to reduced
acetylcholine release at the neuromuscular synapse of the rolling
Nagoya mouse, recorded in an ex vivo diaphragm–phrenic nerve
muscle nerve preparation with intracellular electrophysiological
techniques. Black triangle indicates moment of nerve stimulation
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One may wonder whether the RN mouse may also be a
relevant animal model to study migraine, which is a
common, neurovascular brain disorder of disabling attacks
of headache and associated neurological symptoms [52].
After all, mutations in the CACNA1A gene in humans cause
familial hemiplegic migraine type 1 (FHM1) [5], a rare
subtype of migraine with aura with transient hemiparesis
during the aura phase. FHM is considered a model for the
common forms of migraine because of similar aura and
headache characteristics. Moreover, the majority of FHM
patients also have normal attacks of migraine without
hemiparesis. Interestingly, some 20% of FHM1 patients
also suffer from cerebellar ataxia that is also the prominent
neurological phenotype in RN mice.
However, electrophysiological studies of FHM1-mutated
Cav2.1-transfected cells and dissociated cerebellar neurons
from a recently generated Cacna1a knockin mouse carrying
the FHM1 mutation R192Q [18, 53, 54] indicate that the
consequences of FHM1 mutations on Cav2.1 channel
function are in some important respects opposite to those
of the RN mutation [2]. Whereas FHM1 mutations cause
gain-of-function effects on neuronal Ca
2+ influx with a shift
of channel activation voltage in the negative direction and
increased Cav2.1 current density, the RN mutation causes
reduced Cav2.1 current density and a shift of activation
voltage in the positive direction. In view of these differ-
ences, the RN mouse seems not useful as a model for
(familial hemiplegic) migraine.
Lambert–Eaton Myasthenic Syndrome
Our own neuromuscular electrophysiological analyses and
muscle strength tests of RN mice [9] have revealed that this
mutant shares certain aspects with the paralytic auto-immune
disease LEMS, where auto-antibodies target presynaptic
Cav2.1 channels at the NMJ. Electrophysiological analysis
of synaptic signals at biopsied NMJs of LEMS patients
showed severely reduced ACh release [55], as found at RN
NMJs. A similar presynaptic defect was present at biopsy
NMJs of three congenital myasthenic syndrome patients
without anti-Cav2.1 antibodies or identified CACNA1A
mutation but with symptoms of ataxia [56] and, furthermore,
at biopsy NMJs of two episodic ataxia type 2 patients with
CACNA1A truncation mutations [57]. Conversely, some
LEMS patients have accompanying symptoms of ataxia
[58]. In addition, electromyography performed in LEMS
patients resembles that in RN mice, in that there is a low
initial compound muscle action potential which decrements
during low-frequency nerve stimulation (1–10 Hz). Thus,
although different causes underlie the paralytic symptoms in
RN mice and LEMS patients (i.e., genetic vs. auto-immune),
these similarities indicate that RN mice can serve as a non-
immunological model for (NMJ function) aspects of LEMS
and could be useful for drug studies aiming to improve
treatment of NMJ dysfunction.
Conclusion
The R1262G mutation in the Cav2.1-α1 protein of the RN
mouse causes a reduced voltage sensitivity of Cav2.1 Ca
2+
channels. This presumably leads to reduced Ca
2+ influx in
cerebellar and other neurons that express the channel,
causing disturbed Ca
2+ signaling leading to aberrant expres-
sion of many neuronal proteins and possibly also to the
apoptosis of some neurons. Also, Cav2.1-dependent central
synaptic transmission is likely to be disturbed. Together,
these complex phenomena culminate in the well-described
motor coordination defects of RN mice. It is yet unclear to
which extent noncerebellar regions such as the basal ganglia
contribute to the motor symptoms and whether cerebellar
atrophy is an important factor. Neuromuscular function
analyses together with synaptic studies at the NMJ indicate
that, in addition to the ataxia, the RN phenotype has a
muscle weakness component. Although the RN mouse may
not represent a very good model for common forms of
migraine or not even for FHM1 (defined by CACNA1A
mutations), it may be useful in the experimental study of new
anti-ataxic drugs and drugs that restore disturbed NMJ
function.
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